Invasive Lobular Carcinoma of the Breast
📧 Sign up to get email alerts when something new happens for Invasive Lobular Carcinoma of the Breast.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors [Phase 1]
Phase I study update for the radiopharmaceutical [177Lu]Lu-DFC413 in patients with various solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
A UCSF-led clinical trial registry entry (PLUMB Registry) aims to improve survival in metastatic lobular breast cancer. The study is current…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: [68]GA-FAPI-46 PET/CT for the Diagnosis of Metastatic Lesions in Patients With Lobular Breast Cancer (ICL). [NA]
A clinical trial evaluating GA-FAPI-46 PET/CT for identifying metastatic lesions in invasive lobular carcinoma of the breast; the study is n…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers [Phase 2]
Phase 2 neoadjuvant trial evaluating neratinib for stage I-III HER2-mutated lobular breast cancer, currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Capivasertib Plus Fulvestrant vs. Fulvestrant in Primary High-risk Lobular Breast Cancer [Phase 2]
Phase 2 trial evaluating capivasertib plus fulvestrant versus fulvestrant alone in primary high-risk invasive lobular breast cancer; recruit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE) [Phase 2]
A Phase 2 neoadjuvant study (ROSALINE) investigates targeting ROS1 in combination with endocrine therapy for invasive lobular carcinoma of t…